HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Mitchell Evers Selected Research

Antibodies

1/2023IgA antibody immunotherapy targeting GD2 is effective in preclinical neuroblastoma models.
10/2021The selection of variable regions affects effector mechanisms of IgA antibodies against CD20.
10/2021Anti-GD2 IgA kills tumors by neutrophils without antibody-associated pain in the preclinical treatment of high-risk neuroblastoma.
12/2020Fc Engineering Strategies to Advance IgA Antibodies as Therapeutic Agents.
1/2020Novel chimerized IgA CD20 antibodies: Improving neutrophil activation against CD20-positive malignancies.
1/2019Potent Fc Receptor Signaling by IgA Leads to Superior Killing of Cancer Cells by Neutrophils Compared to IgG.
1/2019Immune Effector Functions of Human IgG2 Antibodies against EGFR.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Mitchell Evers Research Topics

Disease

9Neoplasms (Cancer)
03/2024 - 01/2019
2Neuralgia (Stump Neuralgia)
01/2023 - 10/2021
2Neuroblastoma
01/2023 - 10/2021
1Communicable Diseases (Infectious Diseases)
09/2023
1Lymphoma (Lymphomas)
10/2021
1Pain (Aches)
10/2021
1Hypersensitivity (Allergy)
12/2020
1B-Cell Chronic Lymphocytic Leukemia (Chronic Lymphocytic Leukemia)
01/2018

Drug/Important Bio-Agent (IBA)

7Immunoglobulin G (IgG)IBA
03/2024 - 01/2019
7AntibodiesIBA
01/2023 - 01/2019
6Immunoglobulin A (IgA)IBA
09/2023 - 01/2019
4Monoclonal AntibodiesIBA
10/2021 - 01/2018
3Complement System Proteins (Complement)IBA
03/2024 - 01/2019
2Fc(alpha) receptorIBA
09/2023 - 01/2023
2dinutuximabIBA
01/2023 - 10/2021
1IgA receptor (protein B)IBA
10/2021
1CaspasesIBA
10/2021
1Rituximab (Mabthera)FDA Link
12/2020
1Immune Checkpoint InhibitorsIBA
01/2019
1Neoplasm Antigens (Tumor Antigens)IBA
01/2019
1Cetuximab (Erbitux)FDA Link
01/2019
1necitumumabIBA
01/2019
1ErbB Receptors (EGF Receptor)IBA
01/2019
1Fc Receptors (Fc Receptor)IBA
01/2019
1Tyrosine (L-Tyrosine)FDA Link
01/2019
1Panitumumab (Vectibix)FDA Link
01/2019

Therapy/Procedure

4Therapeutics
01/2023 - 01/2019
2Immunotherapy
09/2023 - 01/2023